Clinical characteristics and outcomes associated with BRAF and NRAS mutations in metastatic melanoma

被引：9
|
作者：
Jakob, J. A. [1 ]
Bassett, R. L. [1 ]
Ng, C. S. [1 ]
Lazar, A. J. F. [1 ]
Alvarado, G. C. [1 ]
Rohlfs, M. L. [1 ]
Richard, J. [1 ]
Gershenwald, J. E. [1 ]
Hwu, P. [1 ]
Kim, K. B. [1 ]
Davies, M. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.8500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8500
引用
收藏
页数：1
相关论文
共 50 条
  • [31] BRAF mutations in metastatic melanoma:: A possible association with clinical outcome
    Kumar, R
    Angelini, S
    Czene, K
    Sauroja, I
    Hahka-Kemppinen, M
    Pyrhönen, S
    Hemminki, K
    CLINICAL CANCER RESEARCH, 2003, 9 (09) : 3362 - 3368
  • [32] Mutational Frequencies of NRAS and BRAF in 119 Metastatic Melanoma Samples
    Tran, T.
    White, R.
    Choppa, P.
    Bloom, K.
    Gutekunst, K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 722 - 722
  • [33] BRAF and NRAS Mutations are Heterogeneous and Not Mutually Exclusive in Nodular Melanoma
    Chiappetta, Caterina
    Proietti, Ilaria
    Soccodato, Valentina
    Puggioni, Chiara
    Zaralli, Roberto
    Pacini, Luca
    Porta, Natale
    Skroza, Nevena
    Petrozza, Vincenzo
    Potenza, Concetta
    Della Rocca, Carlo
    Di Cristofano, Claudio
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2015, 23 (03) : 172 - 177
  • [34] BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients
    Dika, Emi
    Veronesi, Giulia
    Altimari, Annalisa
    Riefolo, Mattia
    Ravaioli, Giulia Maria
    Piraccini, Bianca Maria
    Lambertini, Martina
    Campione, Elena
    Gruppioni, Elisa
    Fiorentino, Michelangelo
    Melotti, Barbara
    Ferracin, Manuela
    Patrizi, Annalisa
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (05) : 664 - 671
  • [35] Somatic BRAF and NRAS mutations in familial melanoma: a GenoMEL study
    Zebary, Abdlsattar
    Omholt, Katarina
    van Nieuwpoort, Frans A.
    Ghiorzo, Paola
    Gruis, Nelleka A.
    Harbst, Katja
    Hayward, Nicholas K.
    Jonsson, Goran B.
    Pjanova, Dace
    Puig, Susana
    Scarra, Giovanna B.
    Whitaker, Linda M.
    Newton-Bishop, Julia
    Hansson, Johan
    CANCER RESEARCH, 2011, 71
  • [36] Prevalence of BRAF and NRAS mutations in cutaneous melanoma patients in Taiwan
    Sheen, Yi-Shuan
    Liao, Yi-Hua
    Liau, Jau-Yu
    Lin, Ming-Hsien
    Hsieh, Yi-Chun
    Jee, Shiou-Hwa
    Chu, Chia-Yu
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2016, 115 (02) : 121 - 127
  • [37] BRAF, KIT, and NRAS testing patterns and results in metastatic melanoma
    Abernethy, Amy P.
    Fung, Chi
    Richardson, Paul
    Eisenberg, Daniel S.
    Connolly, Dominique
    Terry, May
    Feinstein, Ross N.
    Tucker, Melisa
    Miller, Catherine
    Nicacio, Leonardo Viana
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [38] Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
    Goel, Vikas K.
    Lazar, Alexander J. F.
    Warneke, Carla L.
    Redston, Mark S.
    Haluska, Frank G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (01) : 154 - 160
  • [39] BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival
    Akslen, LA
    Angelini, S
    Straume, O
    Bachmann, IM
    Molven, A
    Hemminki, K
    Kumar, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (02) : 312 - 317
  • [40] BRAF and NRAS mutations in melanoma:: potential relationships to clinical response to HSP90 inhibitors
    Banerji, Udai
    Affolter, Annette
    Judson, Ian
    Marais, Richard
    Workman, Paul
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) : 737 - 739
12345